“acetylon-pharmaceuticals” Archives

in
Entry Author Date Location
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future? 08/08/18 San Francisco
Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More 12/09/16 National
Acetylon Crafts New Buyout Deal With Celgene, Spins Out Startup Regenacy 12/02/16 Boston
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out 08/08/16 Boston
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More 01/08/16 Boston
Tech Mogul, Patriots Owner Lavish $73M On Dana-Farber Startup 01/07/16 Boston
Celgene, Versant Shake Again, Cut $30M Deal For Toronto Biotech 04/29/15 New York
East Coast Biotech Roundup: Juno, Editas, Celgene, & More 12/06/13 Boston
Celgene Plunks Down $177M Upfront for OncoMed’s Stem Cell Drugs 12/03/13 San Francisco
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More 08/02/13 Boston
Acetylon Pharmaceuticals Obtains $100,000,000 New Funding Round 07/30/13 Boston
Celgene Nabs Option to Buy Acetylon for More Than $1.7B 07/29/13 Boston
Synchroneuron, Radius, Acetylon, & More Boston Life Sciences News 02/10/12 Boston
Acetylon Pharmaceuticals Secures $15,000,000 New Round 02/09/12 Boston
RXi Splits Up, Zeo Launches Mobile Sleep-Tracking App, Karuna Licenses Schizophrenia Compounds, & More Boston-Area Life Sciences News 09/30/11 Boston
Backed by Eclectic Financiers, Acetylon Begins Trials of Cancer Drug 09/27/11 Boston
Zynga Files For IPO, Brightcove Inks Boston Lease, Lotus Adds $26M, & More Boston-Area Deals News 07/06/11 Boston
Acetylon Adds $27M, Third Rock Leads Lotus Round, InfraReDx Gets $24M, & More Boston-Area Life Sciences News 07/01/11 Boston
Acetylon, Backed by Patriots Owner Bob Kraft, Snags $27M to Develop New Cancer Drugs 06/29/11 Boston
Acetylon Pharmaceuticals Receives $14,600,000 Series B Round 06/29/11 Boston
GSK Backs SpringLeaf, Prexa Nabs $7M from Advent & Shire, Acetylon Gets $5M Partnership, & More Boston-Area Life Sciences News 05/13/11 Boston
Acetylon Nabs $4.9M for Myeloma Drug 05/11/11 Boston
Constant Contact Buys Bantam Live, Forest Pays $1.2B for Clinical Data, Paydiant Scores $7.6M, & More Boston-Area Deals News 02/23/11 Boston
Acetylon Pharma Raises $12.4M 02/22/11 Boston
Acetylon Pharmaceuticals Secures $12,400,000 Series B Financing Round 02/22/11 Boston
Constellation Pharma Hires New CEO, Collects Last $17M of its Series A Financing 08/13/09 Boston
Biogen Idec Faces Suit From Partner Elan, Genzyme Wins European Approval for Stem-Cell Boosting Drug, Alnylam Teams with Tekmira, & More Boston-Area Life Sciences News 08/12/09 Boston
Page 1 of 2 next page »

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Carbonite
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.

© 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.